Measuring plasma B-type natriuretic peptide in heart failure: Good to go in 2004?

Journal of the American College of Cardiology

Volumn 44, Issue 4, 2004, Pages 740-749

  Rodeheffer, Richard J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; PEPTIDE ANTIBODY;

ASSAY; CARBOXY TERMINAL SEQUENCE; CLINICAL PRACTICE; CONGESTIVE HEART FAILURE; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DISEASE MARKER; ECHOCARDIOGRAPHY; HEART FAILURE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE FAILURE; HEART VENTRICLE FAILURE; HUMAN; MASS SCREENING; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; REVIEW; TREATMENT OUTCOME;

BIOLOGICAL MARKERS; HEART FAILURE, CONGESTIVE; HUMANS; MASS SCREENING; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY;

EID: 4143068099     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2004.03.082     Document Type: Review

References (78)

1. E. Braunwald, D.C. Harrison, C.A. Chidsey The heart as an endocrine organ Am J Med 36 1964 1 4
2. A.J. de Bold, H.B. Borenstein, A.T. Veress, H. Sonnenberg A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats Life Sci 28 1981 89 94
3. T. Sudoh, K. Kangawa, N. Minamino, H. Matsuo A new natriuretic peptide in porcine brain Nature 332 1988 78 81
4. H. Yasue, M. Yoshimura, H Sumida Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure Circulation 90 1994 195 203
5. A. Luchner, T.L. Stevens, D.D Borgeson Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure Am J Physiol 274 1998 H1684 9
6. J.R. Dietz Release of natriuretic factor from rat heart-lung preparation by atrial distension Am J Physiol 247 1984 R1093 6
7. J.C. Burnett, P.C. Kao, D.C Hu Atrial natriuretic peptide elevation in congestive heart failure in the human Science 231 1986 1145 1147
8. R.J. Rodeheffer, I. Tanaka, T. Imada, A.S. Hollister, D. Robertson, T. Inagami Atrial pressure and secretion of atrial natriuretic factor into the human central circulation J Am Coll Cardiol 8 1986 18 26
9. A.E.G. Raine, P. Erne, E Burgisser Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure N Engl J Med 315 1986 533 537
10. T.G. Yandle, A.M. Richards, A. Gilbert, S. Fisher, S. Holmes, E.A. Espiner Assay of brain natriuretic peptide (BNP) in human plasma: evidence for high molecular weight BNP as a major plasma component in heart failure J Clin Endocrinol Metab 76 1993 832 838
11. P.J. Hunt, A.M. Richards, M.G. Nicholls, T.G. Yandle, R.N. Doughty, E.A. Espiner Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-proBNP): a new marker of cardiac impairment Clin Endocrinol 47 1997 287 296
12. C.J. Pemberton, M.L. Johnson, T.G. Yandle, E.A. Espiner Deconvolution analysis of cardiac natriuretic peptides during acute volume overload Hypertension 36 2000 355 359
13. R. Kazanegra, V. Cheng, A Garcia A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study J Cardiac Failure 7 2001 21 29
14. W.L. Miller, K.R. Bailey, S.A. Weston, J.C. Burnett Jr, R.J. Rodeheffer Hemodynamic and plasma atrial natriuretic peptide responses to acute digitalis therapy in patients with normal and impaired left ventricular function Eur J Heart Failure 4 2002 63 72
15. M.M. Redfield, L.L. Aarhus, R.S. Wright, J.C. Burnett Jr Cardiorenal and neurohumoral function in a canine model of early left ventricular dysfunction Circulation 87 1993 2016 2022
16. M.M. Redfield, B.S. Edwards, D.M. Heublein, J.C. Burnett Jr Restoration of renal response to atrial natriuretic factor in experimental low-output heart failure Am J Physiol 257 1989 R917 23
17. M.E. Lee, W.L. Miller, B.S. Edwards, J.C. Burnett Jr Role of endogenous atrial natriuretic factor in acute congestive heart failure J Clin Invest 84 1989 1962 1966
18. A. Lerman, R.J. Gibbons, R.J Rodeheffer Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left ventricular dysfunction Lancet 341 1993 1105 1109
19. K. Yamamoto, J.C. Burnett Jr., M Jougasaki Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy Hypertension 28 1996 988 994
20. R.S. Vasan, E.J. Benjamin, M.G Larson Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham Heart Study JAMA 288 2002 1252 1259
21. J.G. Lainchbury, E. Campbell, C.M. Frampton, T.G. Yandle, G. Nicholls, A.M. Richards Brain natriuretic peptide and n-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath J Am Coll Cardiol 42 2003 728 735
22. A.H.B. Wu, A. Smith, S Wieczorek Biological variation for N-terminal pro-and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure Am J Cardiol 92 2003 628 631
23. M.M. Redfield, R.J. Rodeheffer, S.J. Jacobsen, D.W. Mahoney, K.R. Bailey, J.C. Burnett Jr Plasma brain natriuretic peptide concentration: impact of age and gender J Am Coll Cardiol 40 2002 976 982
24. J.G. Lainchbury, A.M. Richards, M.G. Nicholls, E.A. Espiner, T.G. Yandle Brain natriuretic peptide and neutral endopeptidase inhibition in left ventricular impairment J Clin Endocrinol Metab 84 1999 723 729
25. C.M. Florkowski, A.M. Richards, E.A. Espiner, T.G. Yandle, E. Sybertz, C.M. Frampton Low-dose brain natriuretic peptide infusion in normal men and the influence of endopeptidase inhibition Clin Sci 92 1997 255 260
26. I. Loke, I.B. Squire, J.E. Davies, L.L. Ng Reference ranges for natriuretic peptides for diagnostic use are depending on age, gender and heart rate Eur J Heart Failure 5 2003 599 606
27. A. Cataliotti, L.S. Malatino, M Jougasaki Circulating natriuretic peptide concentrations in patients with end-stage renal disease: role of brain natriuretic peptide as a biomarker for ventricular remodeling Mayo Clin Proc 76 2001 1111 1119
28. T. Akiba, K. Tachibana, K. Togashi, M. Hiroe, F. Marumo Plasma human brain natriuretic peptide in chronic renal failure Clin Nephrol 44 1995 S61 4
29. K. Kario, T. Nishikimi, F Yoshihara Plasma levels of natriuretic peptides and adrenomedullin in elderly hypertensive patients: relationships to 24 h blood pressure J Hypertens 16 1998 1253 1259
30. D.F. Ransohoff, A.R. Feinstin Problems of spectrum and bias in evaluating the efficacy of diagnostic tests N Engl J Med 299 1978 926 930
31. K. Yamamoto, J.C. Burnett Jr, E.A. Bermudez, M. Jougasaki, K.R. Bailey, M.M. Redfield Clinical criteria and biochemical markers for the detection of systolic dysfunction J Cardiac Failure 6 2000 194 200
32. A.S. Maisel, J. Koon, P Krishnaswamy Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction Am Heart J 141 2001 367 374
33. E. Lubien, A. DeMaria, P Krishnaswamy Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings Circulation 105 2002 595 601
34. T.A. McDonagh, C.E. Morrison, A Lawrence Symptomatic and asymptomatic left ventricular systolic dysfunction in an urban population Lancet 350 1997 829 833
35. R.B. Devereux, M.J. Roman, M Paranicas A population-based assessment of left ventricular systolic dysfunction in middle-aged and older adults: the Strong Heart Study Am Heart J 141 2001 439 446
36. M.M. Redfield, S.J. Jacobsen, J.C. Burnett, D.W. Mahoney, K.R. Bailey, R.J. Rodeheffer Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic JAMA 289 2003 194 202
37. S.J. Jacobsen, E.J. Bergstralh, H.A Guess Predictive properties of serum prostate-specific antigen testing in a community-based setting Arch Intern Med 156 1996 2462 2468
38. M.T. Fahey, L. Irwig, P. Macaskill Meta-analysis of Pap test accuracy Am J Epidemiol 141 1995 680 689
39. M.M. Redfield, R.J. Rodeheffer, S.J. Jacobsen, D.W. Mahoney, K.R. Bailey, J.C. Burnett Jr Plasma brain natriuretic peptide to detect pre-clinical ventricular systolic or diastolic dysfunction: a community-based study Circulation 109 2004 3176 3181
40. T.A. McDonagh, S.D. Robb, D.R Murdoch Biochemical detection of left ventricular systolic dysfunction Lancet 351 1998 9 13
41. O.W. Neilsen, T.A. McDonagh, S.D. Robb, H.J. Dargie Retrospective analysis of the cost-effectiveness of using plasma brain natriuretic peptide in screening for left ventricular systolic dysfunction in the general population J Am Coll Cardiol 41 2003 113 120
42. M. Nakamura, H. Endo, M. Nasu, N. Arakawa, T. Segawa, K. Hiramori Value of plasma B-type natriuretic peptide measurement for heart disease screening in a Japanese population Heart 87 2002 131 135
43. A.D. Struthers Introducing a new role for BNP: as a general indicator of cardiac structural disease rather than a specific indicator of systolic dysfunction only Heart 87 2002 97 98
44. S. Oottamasathien, E.D. Crawford Should routine screening for prostate-specific antigen be recommended? Arch Intern Med 163 2003 661 662
45. R.M. Hoffman An argument against routine prostate cancer screening Arch Intern Med 163 2003 663 665
46. H. Niinuma, M. Nakamura, K. Hiramori Plasma B-type natriuretic peptide measurement in a multiphasic health screening program Cardiology 90 1998 89 94
47. S.J. Wieczorek, A.H.B. Wu, R Christenson A rapid B-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure: a multicenter evaluation Am Heart J 144 2002 834 839
48. M.R. Cowie, A.D. Struthers, D.A Wood Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care Lancet 350 1997 1349 1353
49. S.P. Wright, R.N. Doughty, A Pearl Plasma amino-terminal pro-brain natriuretic peptide and accuracy of heart-failure diagnosis in primary care J Am Coll Cardiol 42 2003 1793 1800
50. M. Davis, E. Espiner, G Richards Plasma brain natriuretic peptide in assessment of acute dyspnoea Lancet 343 1994 440 444
51. D. Logeart, C. Saudubray, P Beyne Comparative value of Doppler echocardiography and B-type natriuretic peptide assay in the etiologic diagnosis of acute dyspnea J Am Coll Cardiol 40 2002 1794 1800
52. L.K. Morrison, A. Harrison, P. Krishnaswamy, R. Kazanegra, P. Clopton, A. Maisel Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea J Am Coll Cardiol 39 2002 202 209
53. A.S. Maisel, P. Krishnaswamy, R.M Nowak Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure N Engl J Med 347 2002 161 167
54. A.S. Maisel, J. McCord, R.M Nowak Bedside B-type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction J Am Coll Cardiol 41 2003 2010 2017
55. C. Mueller, A. Scholer, K Laule-Kilian Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea N Engl J Med 350 2004 647 654
56. R.W. Troughton, C.M. Frampton, T.G. Yandle, E.A. Espiner, M.G. Nicholls, A.M. Richards Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations Lancet 355 2000 1126 1130
57. G. Palladini, C. Campana, C Klersy Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis Circulation 107 2003 2440 2445
58. A.M. Richards, R. Doughty, M.G Nicholls Neurohumoral prediction of benefit from carvedilol in ischemic left ventricular dysfunction Circulation 99 1999 786 792
59. K.M. Davis, L.C. Fish, D. Elahi, B.A. Clark, K.L. Minaker Atrial natriuretic peptide levels in the prediction of congestive heart failure risk in frail elderly JAMA 267 1992 2625 2629
60. T.J. Wang, M.G. Larson, D Levy Plasma natriuretic peptide levels and the risk of cardiovascular events and death N Engl J Med 350 2004 655 663
61. S.S. Gottlieb, M.L. Kukin, D. Ahern, M. Packer Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure J Am Coll Cardiol 13 1989 1534 1539
62. P.L. Selvais, J.E. Donckier, A Robert Cardiac natriuretic peptides for diagnosis and risk stratification in heart failure: influences of left ventricular dysfunction and coronary artery disease on cardiac hormonal activation Eur J Clin Invest 28 1998 636 642
63. K. Swedberg, P. Eneroth, J. Kjekshus, L. Wilhelmsen Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group Circulation 82 1990 1730 1736
64. J. Koglin, S. Pehlivanli, M. Schwaiblmair, M. Vogeser, P. Cremer, W. von Scheidt Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure J Am Coll Cardiol 38 2001 1934 1941
65. R. Berger, M. Huelsman, K Strecker B-type natriuretic peptide predicts sudden death in patients with chronic heart failure Circulation 105 2002 2392 2397
66. B. Vitrovec, R. Delgado, A. Zewail, C.D. Thomas, B.M. Richartz, B. Radovancevic Prolonged QTc interval and high B-type natriuretic peptide levels together predict mortality in patients with advanced heart failure Circulation 107 2003 1764 1769
67. D.A. Morrow, J.A. de Lemos, M.S Sabatine Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/nonST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICSTIMI-18 J Am Coll Cardiol 41 2003 1264 1272
68. J.A. De Lemos, D.A. Morrow, J.H Bentley The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes N Engl J Med 345 2001 1014 1021
69. T. Jernberg, B. Lindahl, A Siegbahn N-terminal pro-brain natriuretic peptide in relation to inflammation, myocardiac necrosis, and the effect of an invasive strategy in unstable coronary artery disease J Am Coll Cardiol 42 2003 1909 1916
70. J. Svanegaard, K. Angelo-Nielsen, T. Pindborg Plasma concentration of atrial natriuretic peptide at admission and risk of cardiac death in patients with acute myocardial infarction Br Heart J 68 1992 38 42
71. A.M. Richards, M.G. Nicholls, T.G Yandle Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction Heart 81 1999 114 120
72. A.M. Richards, M.G. Nicholls, E.A Espiner B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction Circulation 107 2003 2786 2792
73. V. Cheng, R. Kazanagra, A Garcia A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study J Am Coll Cardiol 37 2001 386 391
74. I.S. Anand, L.D. Fisher, Y.T., et al Chiang., for the Val-HeFT Investigators Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT). Circulation 107 2003 1278 1283
75. N. Kucher, G. Printzen, T. Doernhoefer, S. Windecker, B. Meier, O.M. Hess Low pro-brain natriuretic peptide levels predict benign clinical outcome in acute pulmonary embolism Circulation 107 2003 1576 1578
76. M. ten Wolde, I.I. Tulevski, J.W.M Mulder Brain natriuretic peptide as a predictor of adverse outcome in patients with pulmonary embolism Circulation 107 2003 2082 2084
77. I.L. Gerber, R.A.H. Stewart, M.E Legget Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis Circulation 107 2003 1884 1890
78. T.M. Sutton, R.A.H. Stewart, I.L Gerber Plasma natriuretic peptide levels increase with symptoms and severity of mitral regurgitation J Am Coll Cardiol 41 2003 2280 2287